I dont have a ton of clients, but I do that on the side just cause I like it
Tirzepatide, a dual GLP-1 and GIP receptor agonist, showed even greater weight reduction in the SURMOUNT trials, with some participants achieving 22% body weight loss
So, you know, atherosclerosis, arteriosclerosis, thorotic plaques throughout the arteries of the body, heart disease, strokes, the hypertension, kidney failure, retinopathies, and so they're going blind, no neuropathies, no failure, they're having, you know, lower limbs amputated and these patients who were maybe diagnosed when they were 10 years old, diabetes, and saved from death when they were 12 years old by insulin, like this miracle now, or maybe 27, 30, 35
Lupus rashes can appear in different ways, but a malar rash is one of the most common
Academic and government institutions currently lead the charge in launching new studies, showcasing a robust research ecosystem outside of purely commercial interests